Cargando…
Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway
Pancreatic ductal adenocarcinoma (PDAC) is the most common tumor subtype of pancreatic cancer, which exhibits poor patient prognosis due to the lack of effective biomarkers in the diagnosis and treatment. The present study aimed to identify the potential biomarkers of PDAC carcinogenesis and progres...
Autores principales: | Yao, Li-Chao, Jiang, Xiu-Hua, Yan, Si-Si, Wang, Wei, Wu, Lun, Zhai, Lu-Lu, Xiang, Feng, Ji, Tao, Ye, Lin, Tang, Zhi-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933770/ https://www.ncbi.nlm.nih.gov/pubmed/33692858 http://dx.doi.org/10.3892/ol.2021.12588 |
Ejemplares similares
-
The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma
por: Gao, Zhuqing, et al.
Publicado: (2019) -
TBL1XR1 induces cell proliferation and inhibit cell apoptosis by the PI3K/AKT pathway in pancreatic ductal adenocarcinoma
por: Gu, Jian-Feng, et al.
Publicado: (2020) -
Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma
por: Mortoglou, Maria, et al.
Publicado: (2021) -
Nickel’s Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs
por: Mortoglou, Maria, et al.
Publicado: (2022) -
MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
por: Prinz, Christian, et al.
Publicado: (2022)